LECT2 and metabolic dysfunction-associated steatotic liver disease: Numerous studies have demonstrated the involvement of LECT2 in various liver conditions, including hepatitis, acute liver failure (50), liver fibrosis (59), nonalcoholic fatty liver disease (60), cirrhosis, and HCC (29).